BAP1 Deficiency Inflames the Tumor Immune Microenvironment and Is a Candidate Biomarker for Immunotherapy Response in Malignant Pleural Mesothelioma oleh Duo Xu, MD, PhD, Yanyun Gao, PhD, Haitang Yang, MD, PhD, Marc Spils, MD, Thomas M. Marti, PhD, Tereza Losmanová, MD, Min Su, PhD, Wenxiang Wang, MD, Qinghua Zhou, MD, Patrick Dorn, MD, Yongqian Shu, MD, PhD, Ren-Wang Peng, PhD